Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

a.prnews_a
{
color:blue;
}
li.prnews_li
{
font-size:8pt;
font-family:”Arial”;
color:black;
}
p.prnews_p
{
font-size:0.62em;
font-family:”Arial”;
color:black;
margin:0in;
}
 

Canada NewsWire

MONTREAL and CHARLOTTE, N.C.,Nov. 23, 2020/CNW/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:

  • The Piper Sandler 32ndVirtual Annual Healthcare Conference.
  • The Evercore ISI 3rdAnnual HealthCONx Conference onThursday, December 3, 2020at4:20 p.m. Eastern Time.

A replay of the pre-recorded Piper Sandler fireside chat is currently available in the News & Events section of Milestone’s website atwww.milestonepharma.com, and a live webcast of the Evercore fireside chat can be accessed in the same section of Milestone’s website. An archived replay of the webcasts will be available on the same website for approximately 90 days following the presentations.About Milestone PharmaceuticalsMilestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Milestone Pharmaceuticals operates inCanadaandthe United States. For more information, visitwww.milestonepharma.comand follow the Company on Twitter at @MilestonePharma.ContactDavid PittsArgot Partners212-600-1902[email protected]

(PRNewsfoto/Milestone Pharmaceuticals)

CisionView original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301178279.html

SOURCE Milestone Pharmaceuticals, Inc.CisionView original content to download multimedia:http://www.newswire.ca/en/releases/archive/November2020/23/c5321.html